Select Page

Women in Ophthalmology Podcasts

10 minutes of science is a new podcast series from Women in Ophthalmology. Each edition features an expert in their field discussing an article of their choosing. These articles have been selected due to their impact on the real-world practice of ophthalmology. The series is aimed at the general comprehensive ophthalmologists and includes topics across a range of subspecialities. Hosted by Women in Ophthalmology Deputy Chair, Dr Robyn Troutbeck, we welcome you to listen to 10 minutes of science.

This series was made possible with support from Johnson & Johnson Vision.

The Podcasts

1. Rituximab for Non-infectious Uveitis and Scleritis

Is rituximab a wonder-drug? Dr Diana Conrad, Director of the Uveitis Service at the Royal Women’s and Children’s Hospital (the only speciality uveitis service in Queensland) explores Rituximab for non-infectious Uveitis and Scleritis. Dr Conrad notes an impressive response rate to rituximab for patients where first and second line treatments have failed. Given the success of rituximab, and the biosimilars entering the market, Diana includes some important messages for ophthalmologists using the drug.

2. Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage from Proliferative Diabetic

Dr Cheryl Au, current medical retinal fellow at Westmead Hospital, explores Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage from Proliferative Diabetic Retinopathy. She was prompted to review the article due to frequent presentation of patients presenting with vitreous haemorrhage from PDR, and the desire to identify evidence-based guidelines for best visual outcomes once intervention is decided. Dr Au explores the robustness of the study, as well as explaining the outcomes and how these can be used to guide clinical practice.

3. Selective Laser Trabeculoplasty: A Review

Selective laser trabeculoplasty (SLT) has become an essential part of glaucoma management. Dr Alina Zeldovich explores Selective laser trabeculoplasty: A review published in RANZCO’s own Clinical and Experimental Ophthalmology. Dr Zeldovich is a cataract surgeon who has been using SLT more frequently on her glaucoma patients. She discusses the significance of this review to her own clinical practice. Hear more about the article, including the various subgroups of glaucoma where SLT is being used and what outcomes it is achieving.

4. Eplerenone for Chronic Central Serous Chorioretinopathy in Patients with Active, Previously Untreated Disease for more than 4 Months (VICI)

The VICI trial is highly topical. Dr Narme Deva, Consultant Ophthalmologist & Honorary Senior Lecturer at the University of Auckland, explores the Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial. She explains the results are unequivocal and based on a robust trial of 114 patients. Eplerenone does not improve BCVA in people with chronic CSCR after 12 months of treatment. As ever, Dr Deva reminds listeners that evidence-based medicine includes using reliable data to make decisions, even when patients and ophthalmologists are faced with limited treatment options to prevent vision loss.

5. Clinical Results of Topgraphy-based Customized Ablations in Highly Aberrated Eyes and Karatoconus/ectasia with Cross-linking

On the laser’s edge – breaking taboos! Dr Aanchal Gupta is the Director of Training for the South Australian Training network and a Senior Clinical lecturer at the University of Adelaide. She reviews Clinical results of topography-based customized ablations in highly aberrated eyes and keratoconus/ectasia with cross-linking, the article as written by her fellowship mentors that started her interest in refractive surgery. The results demonstrate how laser platforms can go beyond routine vision correction. Irregular astigmatism, keratoconus patients and those with decentred ablations can be successfully treated with laser. This allows patients to avoid rigid contact lenses, transplants or glasses with suboptimal vision. Do the results last? What are the long-term outcomes? What can go wrong? Dr Gupta explores…

6. Accuracy of Intraocular Lens Power Formulas Modified for Patients with Keratoconus

Which IOL formula should we use prior to cataract surgery in patients with keratoconus? Are the newer formulae with keratoconus modifications more accurate than the regular formulae that we are used to using? What should be our refractive target for these cases and how does it vary according to severity of the cone? Can we aim for spectacle independence? Dr Jacqueline Beltz, Cornea, Cataract and Refractive Surgeon from Melbourne explains why refractive outcomes are tricky to predict in eyes with keratoconus. She explores Accuracy of Intraocular Lens Power Formulas Modified for Patients with Keratoconus by Jack Kane and colleagues that seeks to answer these very questions. Tune in to find out!

7. Laser-assisted in Situ Keratomileusis Long Term Outcomes in Late Adolescence

Dr Tanya Trinh – Coming

8. The Pneumatic Retinopexy vs. Vitrectomy for the Management of Primary Rhegmatogenous Retinal Detachment Outcomes Randomized Trial (PIVOT)

Dr Mali Okada is a consultant at the RVEEH and senior researcher at CERA. In this podcast, she discusses the various management options of retinal detachment. Pneumatic retinopexy is routinely used as the first line treatment in many parts of the world for superior retinal detachments, but this is not always the case in Australia and New Zealand where vitrectomy is preferred. The PIVOT study unpacks the issues, looking at repeat visits, surgical and visual outcomes, requirement for follow-up cataract surgery and more. The study has some limitations but is thought-provoking. It is essential to define the markers of success to support surgeons in determining the best course of action for their patients.

9. Periocular Triamcinolone vs Intravitreal Triamcinolone vs Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs Intravitreal Corticisteroids for Uveitic Macular Edema (POINT) Trial

Dr Priya Samalia is a medical retina and uveitis fellow working at the Royal Victorian Eye and Ear Hospital. She examines the POINT trial on effectiveness of Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the treatment of non-infectious uveitic macular oedema. Dr Samalia explains that the trail is important because macular oedema is a common cause of vision loss for patient with uveitis and management can be challenging. The paper is a head-to-head comparison and broadly represents a real-world patient mix. While it finds intravitreal treatments are superior, Priya notes there are valid reasons to perform periocular injections.

10. Associations Between Anterior Segment Parameters and Rotational Stability of a Plate-haptic Toric Intraocular Lens

At face value – does the data always support the conclusion? Dr Madeleine Adams, a cataract surgeon and comprehensive ophthalmologist with a PhD from the University of Melbourne for her research into age-related macular degeneration, offers a cautionary message about always critically scrutinising data presented in papers and coming to your own conclusion on whether the data supports the conclusions. In the case of Associations between anterior segment parameters and the rotational stability of a plate-haptic toric intraocular lens, with a closer look, the data aren’t so convincing.

11. Factors Affecting Corneal Incision Position During Femtosecond Laser-assisted Cataract Surgery

Dr Kerrie Meades was the first female ophthalmologist to perform laser vision correct in Australia. In this podcast, Dr Meades discusses the article Factors affecting corneal incision position during femtosecond laser-assisted cataract surgery. Kerrie was prompted to explore this topic due to a lack of precision from laser for the second incision. Tilt and displacement can affect the translation of the program of the laser and the actual incision. As such, OCT guidance is needed for the secondary incision, as you do for the primary incision. Kerrie provides an insight into how patient behaviour and anatomy can affect docking, and therefore incisions.

Last updated: November 29, 2021

Get in Touch

Do you have any queries or comments about our website, our products or any  of our services?
RANZCO acknowledges our First Australians, the Traditional Custodians of the land
on which we live and work, and pays respect to Elders past, present and emerging.
Gadigal people of the Eora Nation are the traditional custodians of the land
where the RANZCO head office is located.